Literature DB >> 10850645

Appearance of dissociable and cross-linked hemoglobins in the renal hilar lymph.

B Matheson1, A Razynska, H Kwansa, E Bucci.   

Abstract

Unlike unmodified dissociable bovine hemoglobin (UHb), cross-linked hemoglobins do not dissociate into dimers, do not cross the glomerular filter, and are retained in the plasma for a longer time. Renal peritubular capillaries, which are different from the glomerulus, allow the passage of molecules as large as albumin into the renal interstitium. Cross-linked hemoglobins should pass across these capillaries, enter the renal interstitium, and drain through the renal lymphatics. The present experiments were done in anesthetized rats to determine the appearance of UHb, an intramolecularly cross-linked tetrameric hemoglobin (DECHb), and a polymerized bovine hemoglobin (PHb) of larger molecular size into the renal hilar lymph. Renal hilar lymph samples were obtained before and after an isovolemic exchange of 2 mL/100 g rat weight of a 6% solution of each hemoglobin for blood. The behavior of a 5% solution of Evan's blue-labeled albumin was also determined for comparison. After exchange, the Initial plasma concentration of each of the proteins was in excess of 20 mg/mL. UHb appeared both in urine and lymph. DECHb, PHb, and albumin were absent from the urine but appeared promptly in the renal hilar lymph and reached concentrations at least 30% that of plasma. PHb had a significantly smaller lymph clearance (in microliters per minute) and longer plasma half-time than the other nondissociable proteins. These findings indicate that DECHb and PHb, although not filtered, pass across peritubular capillaries and readily enter the renal interstitial space. The passage of the larger molecular-sized PHb may be hindered relative to the other proteins in passage across peritubular and other systemic capillaries.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10850645     DOI: 10.1067/mlc.2000.106458

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  9 in total

1.  Development of zero-link polymers of hemoglobin, which do not extravasate and do not induce pressure increases upon infusion.

Authors:  Enrico Bucci; Herman Kwansa; Raymond C Koehler; Barbara Matheson
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2007

2.  Down selection of polymerized bovine hemoglobins for use as oxygen releasing therapeutics in a guinea pig model.

Authors:  Jin Hyen Baek; Yipin Zhou; David R Harris; Dominik J Schaer; Andre F Palmer; Paul W Buehler
Journal:  Toxicol Sci       Date:  2012-03-12       Impact factor: 4.849

Review 3.  The Role of Circulating Cell-Free Hemoglobin in Sepsis-Associated Acute Kidney Injury.

Authors:  V Eric Kerchberger; Lorraine B Ware
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

4.  Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs.

Authors:  Felicitas S Boretti; Paul W Buehler; Felice D'Agnillo; Katharina Kluge; Tony Glaus; Omer I Butt; Yiping Jia; Jeroen Goede; Claudia P Pereira; Marco Maggiorini; Gabriele Schoedon; Abdu I Alayash; Dominik J Schaer
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

Review 5.  Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.

Authors:  Dominik J Schaer; Paul W Buehler; Abdu I Alayash; John D Belcher; Gregory M Vercellotti
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

Review 6.  Mechanisms of haemolysis-induced kidney injury.

Authors:  Kristof Van Avondt; Erfan Nur; Sacha Zeerleder
Journal:  Nat Rev Nephrol       Date:  2019-08-27       Impact factor: 28.314

7.  Apohemoglobin-haptoglobin complexes attenuate the hypertensive response to low-molecular-weight polymerized hemoglobin.

Authors:  Donald A Belcher; Carlos Munoz; Ivan S Pires; Alexander T Williams; Pedro Cabrales; Andre F Palmer
Journal:  Blood Adv       Date:  2020-06-23

8.  Molecular Design Properties of OxyVita Hemoglobin, a New Generation Therapeutic Oxygen Carrier: A Review.

Authors:  John P Harrington; Hanna Wollocko
Journal:  J Funct Biomater       Date:  2011-12-16

Review 9.  Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development.

Authors:  Dominik J Schaer; Francesca Vinchi; Giada Ingoglia; Emanuela Tolosano; Paul W Buehler
Journal:  Front Physiol       Date:  2014-10-28       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.